AB

Amit Baloo Garud

Active Director Designated Partner DIN 10018544
DIN 10018544 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Amit Baloo Garud

Data last updated:

Amit Baloo Garud is a Designated Partner at Chintamani Multispeciality Hospital Llp (since 2022). The company operates in Healthcare.

DIN 10018544
Primary Designation Designated Partner
Industry Healthcare
First Appointment 01 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Sep 20222022Active

Board colleagues of Amit Baloo Garud

Directorship timeline

Open interactive timeline →
Chintamani Multispeciality Hospital Llp
Premium access

Shareholding and investment profile for Amit Baloo Garud

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Baloo Garud

Amit Baloo Garud currently holds 1 directorship: Chintamani Multispeciality Hospital Llp (Designated Partner, since 01 Sep 2022).

Amit Baloo Garud was first appointed on 01 Sep 2022 as Designated Partner at Chintamani Multispeciality Hospital Llp.

The current boards of Amit Baloo Garud's companies include Amol Dnyandeo Banait (Chintamani Multispeciality Hospital Llp), Pradeep Bhagwan Shelar (Chintamani Multispeciality Hospital Llp), Sushil Ramakant Patil (Chintamani Multispeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available